Michelle Choe

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial

Nicholas A. Vitanza, Rebecca Ronsley, Michelle Choe et al. · Nature Medicine · 2025 · 131 citations · Full text

Medicine, Neurology, Oncology +17

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor

Benjamin Lerman, Yimei Li, Cecilia Carlowicz et al. · Journal of Clinical Oncology · 2022 · 42 citations

Medicine, Oncology, Pharmacotherapy +13

Treatment of central giant cell granuloma in children with denosumab

Michelle Choe, Valeria Smith, M. Fatih Okcu et al. · Pediatric Blood & Cancer · 2020 · 37 citations

Medicine, Oncology, Pediatrics +13